Industrial policy and medicines in Brazil: state, markets and sectoral arrangement

• Grant number: 14/07725-3
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• Start date: September 01, 2014
• End date: November 30, 2016
• Field of knowledge: Applied Social Sciences - Administration - Public Administration
• Agreement: Coordination of Improvement of Higher Education Personnel (CAPES)
• Principal Investigator: Regina Silvia Viotto Monteiro Pacheco
• Grantee: Elize Massard da Fonseca
• Host Institution: Escola de Administração de Empresas de São Paulo (EAESP). Fundação Getúlio Vargas (FGV). São Paulo , SP, Brazil
• Associated scholarship(s): 15/20143-6 - Public-private partnerships in the pharmaceutical sector: an exploratory investigation of the European Union experience, BE.EP.PD

Abstract

Few developing countries understand the production of medicines as an industrial strategy as Brazil. These countries are usually discouraged to adopt industrial policies for this sector given the associated costs; on the other hand, they are encouraged to promote access to medicines. How can this dilemma be balanced? How can innovations in public policies in Brazil contribute to understanding and overcoming the contradiction between the availability of health inputs and social protection policies? Previous studies have analysed the implications of health industrial policy for economic development. This project takes a different approach and looks at the political action of relevant actors in the health sector as the main explanatory mechanism, arguing that the capacity of the Ministry of Health to coordinate policies, the influence of a community of specialists, and the gain in innovative capacity of the private local pharmaceutical industry have all been crucial to the formulation and development of this agenda. This qualitative research will conduct a documentary investigation and in depth interviews. It will trace the process of negotiation for the different public policies promoted under the Health Industry Complex strategy; the agendas of regional governments regarding the public laboratories and their relationships with the national policy; and the mechanisms to finance and monitor the industrial health policy between 2003 and 2013. Therefore, this study contributes to understanding of the political process of health industry policy as well as the dynamic of interest groups in Brazil, whose literature still focuses on the structure of corporate representation. (AU)

Scientific publications

(4)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

DA FONSECA, ELIZE MASSARD; BASTOS, FRANCISCO INACIO. Implementing Intellectual Property of Pharmaceuticals in Middle-Income Countries: A Case Study of Patent Regulation in Brazil. JOURNAL OF HEALTH POLITICS POLICY AND LAW, v. 41, n. 3, p. 423-450, JUN 2016. (14/07725-3)

DA FONSECA, ELIZE MASSARD; SHADLEN, KENNETH C.. Promoting and regulating generic medicines: Brazil in comparative perspective. Revista Panamericana de Salud Pública = Pan American Journal of Public Health, v. 41, 2017. (15/18604-5, 14/07725-3)

DA FONSECA, ELIZE MASSARD. Relevance of variation in use of terminology to define generic pharmaceutical products. Revista Panamericana de Salud Pública = Pan American Journal of Public Health, v. 37, n. 2, p. 5-pg., 2015-02-01. (14/07725-3)

DA FONSECA, ELIZE MASSARD. How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health-industry complex in Brazil. GLOBAL PUBLIC HEALTH, v. 13, n. 4, p. 489-502, 2018. (15/18604-5, 14/07725-3)